Oncologix Tech Inc. (OTCBB: OCLG) announced today that its wholly owned subsidiary Oncologix Corporation ("Oncologix") has decided to update its development plans to add a Feasibility Clinical Study with its Oncosphere System for the treatment of liver cancers.

Oncologix Tech Inc.'s (OTCBB: OCLG) wholly owned subsidiary, Oncologix Corporation, announced today that the Institut de Cardiologie de Montreal (Montreal Heart Institute) and Dr.

GRAND RAPIDS, Mich., Feb. 1 /PRNewswire-FirstCall